We are live on ! Find out more
ADILW

Adial Pharmaceuticals Warrant
ADILW

Delisted

ADILW was delisted on the 27th of July, 2023.

Back to rankings

3 hedge funds and large institutions have $7K invested in Adial Pharmaceuticals Warrant in 2019 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more funds holding

Funds holding: 2 → 3 (+1)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

42% less capital invested

Capital invested by funds: $12K → $7K (-$5K)

Holders
3
Holders Change
+1
Holders Change %
+50%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$1.85K
2
WAM
Wolverine Asset Management
Illinois
+$146

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$5.17K
Name Holding Trade Value Shares
Change 		Change in
Stake
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$4K -$5.17K -7,069 -39%
UBS Group
2
UBS Group
Switzerland
$3K +$1.85K +2,536 +62%
WAM
3
Wolverine Asset Management
Illinois
– +$146 +200 New

ADILW Hedge Fund Activity: Q1 2019 in Review

3 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Adial Pharmaceuticals Warrant (ADILW) for Q1 2019, worth a combined $7K — down 42% from $12K a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new ADILW positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.

The largest buyer was UBS Group, adding an estimated $1.85K. The largest seller was Susquehanna International Group, cutting an estimated $5.17K.

  • 3 institutional investors held Adial Pharmaceuticals Warrant (ADILW) as of Q1 2019, up from 2 in Q4 2018.
  • Funds reported $7K of Adial Pharmaceuticals Warrant stock for Q1 2019, down 42% quarter-over-quarter.
  • 1 fund opened new Adial Pharmaceuticals Warrant positions in Q1 2019 and 0 closed out, a net change of +1 holder.
  • The largest Adial Pharmaceuticals Warrant buyer in Q1 2019 was UBS Group, an estimated $1.85K added.
  • The largest Adial Pharmaceuticals Warrant seller in Q1 2019 was Susquehanna International Group, an estimated $5.17K sold.

Based on aggregated 13F filings for Q1 2019.